Announcements Trials
Browse Landscape

Phase

Phase 3 11Phase 2 5Phase 1 4Phase 1/2 2Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Meningeal Carcinomatosis 3Lung Neoplasms 3Non-squamous Non-small Cell Lung Cancer 2Solid Tumor Cancer 1NSCLC 1Lymphatic Metastasis 1Carcinoma 1Carcinogenesis 1Advanced Non-squamous Non-Small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

Radiotherapy 2Practice Guidelines as Topic 2Heavy Ion Radiotherapy 2seocalcitol 1pembrolizumab 1Yoga 1X-Rays 1Tomography, Optical Coherence 1Surveys and Questionnaires 1Standard of Care 1Sentinel Lymph Node Biopsy 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiofrequency Ablation 1Pluvicto 1Platinum Compounds 1Pemetrexed 1Nurses 1Nivolumab 1Nimorazole 1NF protocol 1Magnetic Resonance Spectroscopy 1Lasers, Solid-State 1Lasers, Gas 1Itraconazole 1Inulin 1Interviews as Topic 1Hearing 1Fluorodeoxyglucose F18 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma × Pemetrexed × Clear all
NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Tang-Du Hospital

Phase NA Not yet recruiting
28 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡